Skip to content

Clinical trials

Phase 1 Bacterial Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bacterial Infections Phase: Phase 1 Country / region: United States Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20081
20093
20101
20111
20123
20137
20144
20152
20167
20174
20184
20192
20204
20216
20223
20233
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed60
Terminated4
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline13
Qpex Biopharma, Inc.7
National Institute of Allergy and Infectious Diseases (NIAID)5
Evopoint Biosciences Inc.4
Tetraphase Pharmaceuticals, Inc4
Pfizer3
Debiopharm International SA2
Melinta Therapeutics, Inc.2
Theravance Biopharma2
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bacterial Infections66
HIV Infections3
Infections3
Acquired Immunodeficiency Syndrome2
Mycoses2
Urinary Tract Infections2
AIDS-Related Complex1
AIDS-Related Opportunistic Infections1
Chronic Disease1
Chronic Pain1

Trials

Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.